Molecular Screening Method for Preeclampsia (PREMOM)

CompletedOBSERVATIONAL
Enrollment

9,586

Participants

Timeline

Start Date

September 23, 2021

Primary Completion Date

March 27, 2024

Study Completion Date

March 27, 2024

Conditions
Preeclampsia
Interventions
PROCEDURE

Peripheral blood collection in cases group

Maternal peripheral blood will be collected 3 times during pregnancy (1st, 2nd and 3rd trimester) and clinical data compiled in cases group

PROCEDURE

Peripheral blood collection in control group

Maternal peripheral blood will be collected 3 times during pregnancy (1st, 2nd and 3rd trimester) and clinical data compiled in control group

Trial Locations (15)

Unknown

Hospital Universitario de Torrejón, Torrejón de Ardoz

Hospital General Universitario Santa Lucía, Cartagena

Hospital Universitario y Politécnico La Fe, Valencia

Hospital Universitario Cruces, Barakaldo

Complejo Hospitalario Universitario de Albacete, Albacete

Complejo Hospitalario Universitario Insular Materno Infantil, Albacete

Hospital General de Alicante, Alicante

Hospital General de Castellón, Castellon

Hospital Universitario Reina Sofía, Córdoba

Hospital Universitario Puerta de Hierro Majadahonda, Madrid

Hospital Clinico Universitario Virgen de la Arrixaca, Murcia

Hospital Universitario de Canarias, Santa Cruz de Tenerife

Hospital del Río Hortega, Valladolid

Hospital Clínico Universitario Lozano Blesa, Zaragoza

Hospital Universitario Miguel Servet, Zaragoza

All Listed Sponsors
lead

iPremom

INDUSTRY

NCT04990141 - Molecular Screening Method for Preeclampsia (PREMOM) | Biotech Hunter | Biotech Hunter